SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012662
Filing Date
2020-08-14
Accepted
2020-08-14 07:36:04
Documents
72
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocgn-20200630.htm   iXBRL 10-Q 1515332
2 EX-31.1 ocgn-20200630x10qxex311.htm EX-31.1 11877
3 EX-31.2 ocgn-20200630x10qxex312.htm EX-31.2 11869
4 EX-32.1 ocgn-20200630x10qxex321.htm EX-32.1 8980
  Complete submission text file 0001628280-20-012662.txt   6874700

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20200630.xsd EX-101.SCH 47559
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocgn-20200630_cal.xml EX-101.CAL 81557
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocgn-20200630_def.xml EX-101.DEF 244930
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20200630_lab.xml EX-101.LAB 560118
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20200630_pre.xml EX-101.PRE 391129
10 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20200630_htm.xml XML 1129341
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36751 | Film No.: 201101374
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences